Fawzy Elbarbry
- Molecular Biology
- Pharmacology top 2%
- Pharmacology top 5%
- Complementary and alternative medicine top 2%
- Infectious Diseases top 10%
- Co-authors
- Ahmed ShokerAshim MalhotraJane AlcornAhmed RaghebR. Brigg TurnerEric ChangAhmed M. Abdel‐MegiedKyle John Wilby
- Topics
- Pharmacogenetics and Drug Metabolism (13 papers)Eicosanoids and Hypertension Pharmacology (9 papers)Antibiotics Pharmacokinetics and Efficacy (9 papers)
- Journals
- SHILAP Revista de lepidopterologíaThe FASEB JournalBiochemical and Biophysical Research Communications
- Partner nations
- United StatesEgyptCanada
In The Last Decade
Fawzy Elbarbry
74 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 131
- Molecular Biology 340
- Pharmacology 234
- Pharmacology 225
- Complementary and alternative medicine 223
- Infectious Diseases 140
Countries citing papers authored by Fawzy Elbarbry
This map shows the geographic impact of Fawzy Elbarbry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fawzy Elbarbry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fawzy Elbarbry more than expected).
Fields of papers citing papers by Fawzy Elbarbry
This network shows the impact of papers produced by Fawzy Elbarbry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fawzy Elbarbry. The network helps show where Fawzy Elbarbry may publish in the future.
Co-authorship network of co-authors of Fawzy Elbarbry
This figure shows the co-authorship network connecting the top 25 collaborators of Fawzy Elbarbry. A scholar is included among the top collaborators of Fawzy Elbarbry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fawzy Elbarbry. Fawzy Elbarbry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 7 | |
| 6 | 14 | |
| 7 | 27 | |
| 8 | A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients | 12 |
| 9 | 3 | |
| 10 | 12 | |
| 11 | 8 | |
| 12 | Modulation of drug metabolizing enzymes by dietary doses of sulforaphane; role in its antihypertensive and anti-oxidant effect in spontaneously hypertensive rats | 2 |
| 13 | 13 | |
| 14 | 28 | |
| 15 | 19 | |
| 16 | 46 | |
| 17 | 4 | |
| 18 | 20 | |
| 19 | 30 | |
| 20 | 46 |
About Fawzy Elbarbry
Fawzy Elbarbry is a scholar working on Pharmacology, Biochemistry and Transplantation, having authored 76 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (13 papers), Eicosanoids and Hypertension Pharmacology (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). The work is most often cited by research in Complementary and alternative medicine (223 citations), Pharmacology (234 citations) and Transplantation (70 citations). Fawzy Elbarbry has collaborated with scholars based in United States, Egypt and Canada. Frequent co-authors include Ahmed Shoker, Ashim Malhotra, Jane Alcorn, Ahmed Ragheb, R. Brigg Turner, Eric Chang, Ahmed M. Abdel‐Megied, Kyle John Wilby, Reza Karimi and Patrick J. McNamara. Their work appears in journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.